Statistics
Publications
2
Citations
25
H-Index
2
Active since
2023
Affiliations
Iin Narwanti is an author at Universitas Ahmad Dahlan specializing in cancer pharmacology, molecular oncology, and drug discovery.
Publications per year
2023–2024
2
2
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Bidyadhar Sethy, Richa Upadhyay, Iin Narwanti et al. · APOPTOSIS · 2024 · 10 citations · Full text
1–2 of 2